ABSTRACT Catecholamine-induced triggered activity is thought to be caused by intracellular calcium overload mediated by elevation of intracellular cyclic AMP (cAMP). Although shown to occur in isolated preparations, evidence supporting its clinical existence has been lacking. Electrophysiologic studies were performed in four patients with structurally normal hearts who had exertionally related sustained ventricular tachycardia (VT). Programmed stimulation reproducibly initiated and terminated VT in all patients. Induction of tachycardia was also facilitated by infusion of isoproterenol. Adenosine, an endogenous nucleoside, whose only known electrophysiologic effect on ventricular myocardium and Purkinje fibers is antagonism of catecholamine-induced stimulation of intracellular cAMP production, reproducibly terminated all episodes of VT. The tachycardia was also terminated by intravenous verapamil and by the Valsalva maneuver and/or carotid sinus massage. ,(-Adrenergic receptor blockade with propranolol either terminated or prevented induction of VT during programmed stimulation or catecholamine challenge. Adenosine was also administered during VT to 14 patients whose arrhythmias fulfilled standard criteria for reentry, two of whom also had exercise-induced VT. Adenosine, at a dose (112.5 to 225 ,ug/kg iv) sufficient to cause either sinus slowing/arrest or ventriculoatrial block during ventricular pacing, failed to slow or terminate any episode of VT in these patients. Verapamil and autonomic modulation were also ineffective in this group of patients. Adenosine, verapamil, vagal maneuvers (acetylcholine), and ,f-adrenergic receptor blockade are all known to decrease the slow-inward calcium current either directly by modulating calcium channels or indirectly by inhibiting production of cellular cAMP. Therefore the observation in this study that interventions that lower intracellular cAMP either terminate or prevent induction of VT in patients with structurally normal hearts and exercise-induced VT suggests that the mechanism of tachycardia may be cAMPmediated triggered activity. Circulation 74, No. 2, 270-280, 1986. VENTRICULAR TACHYCARDIA (VT) is usually attributed to one of two mechanisms, automaticity or reentry.1"2 A third mechanism of arrhythmia, triggered activity, has been demonstrated in studies of isolated tissues and single cells exposed to cardiac glycosides, high [Ca2l]0 or catecholamines.3-1 This rhythm is initi-
trant rhythms by the response of the arrhythmia to pharmacologic and autonomic interventions that are known to lower intracellular cAMP. In particular, the response of VT to adenosine, an endogenous nucleoside whose only known electrophysiologic effect on ventricular myocardium and Purkinje fibers is inhibition of cAMP-mediated catecholamine effects, 8 14 was evaluated.
This study describes the effects of adenosine in four patients with exercise-induced VT and in a control group of patients with reentrant VT.
Methods
Electrophysiologic study. All studies were performed with patients in the unsedated, postabsorptive state after informed consent had been obtained. All antiarrhythmic agents were discontinued for at least five half-lives before initial evaluation; however, results for adenosine reported in five of 14 control patients with reentrant VT (group II; see below) were obtained during follow-up study with the patients on antiarrhythmic drugs. Four quadripolar electrode catheters were inserted percutaneously and advanced under fluoroscopic guidance to the high right atrium, coronary sinus, right ventricular apex, and atrioventricular junction for recording of the His bundle electrogram. Bipolar intracardiac recordings were filtered at 30 to 500 Hz and simultaneously displayed with three ECG leads on a multichannel oscilloscope (Electronics for Medicine, VR-16, White Plains, NY). Data were stored on magnetic tape (Honeywell model 101, Waltham, MA) and were later retrieved on photographic paper for illustrative purposes. Real-time recordings were made with an ink-jet recorder (Siemens Elema Mingograph, Iselin, NJ). Stimulation was performed with a programmable stimulator and an isolated constant-current source (Bloom Associates, Narberth, PA). Stimuli were delivered as rectangular pulses of 2 msec duration at four times diastolic threshold.
Our stimulation protocol has been previously reported and includes the introduction of single, double, and triple extrastimuli during sinus rhythin and at several paced cycle lengths, and rapid burst pacing from multiple atrial and ventricular sites. '5 Pharmacologic assessment. Initiation of tachycardia in response to infusion of catecholamines was tested with isoproterenol. The infusion rate was started at 2 ,ug/min and was increased by 2 ,ug/min every 2 min until an infusion rate of 14 gg/min was achieved, 90% of age-predicted maximal heart rate was reached, VT occurred, or side effects developed.
The effects of intravenous adenosine on VT were evaluated.
Crystalline adenosine (Sigma Chemical Co., St. Louis) was dissolved in normal saline at a concentration of 5 mg/ml and was prepared under sterile conditions. Adenosine concentrations were confirmed by high-pressure liquid chromatography. 16 18 Catecholamine facilitation of VT was defined as (1) initiation of clinical VT during infusion of isoproterenol alone; (2) induction of VT during both programmed stimulation and simultaneous infusion of isoproterenol (4 ,ug/min) with a less vigorous induction protocol than with programmed stimulation alone, e.g., requiring a single ventricular extrastimulus rather than double extrastimuli; or (3) induction of sustained VT during simultaneous programmed stimulation and isoproterenol infusion when either one alone resulted in only nonsustained VT. The response to slow-inward channel blockade was assessed by administration of 10 mg of intravenous verapamil during sustained tachycardia.
Autonomic assessment. During tachycardia, several vagal maneuvers were tested to assess autonomic effect on the rhythm. Right and left carotid sinus massage was performed sequentially and patients were instructed to perform the Valsalva maneuver. The effect of ,3-adrenergic blockade on initiation or termination of VT was evaluated after intravenous infusion of propranolol (0.1 to 0.2 mg/kg).
The procedures described in this study were performed in accordance with a protocol approved by the Human Investigations Committee of the University of Virginia.
Results
Group I: Exercise-induced VT (no structural heart disease). Relevant patient characteristics are summarized in table 1. All patients were between 25 and 32 years old and had clinically documented recurrent, exertionally (exercise) related sustained VT that lasted at least 1 hr and required medical intervention ( several minutes before termination with programmed stimulation. VT was terminated with ventricular overdrive pacing in all patients (figure 1). In addition, coupled ventricular extrastimuli terminated VT in patients 2 and 4, whereas atrial pacing was able to terminate VT in patient 4. The configuration of VT in the first two patients showed two discrete monomorphic morphologies during separate episodes, whereas patients 3 and 4 showed only one morphologic tachycardia (table 2) . Right and left ventricular activation mapping performed in patient 1 during VT (left bundle branch block morphology) identified earliest ventricular activation in the region of the right ventricular outflow tract.
Response to isoproterenol. Isoproterenol alone did not initiate VT in patient 1; however, the infusion rate was limited to 4 ,g/min because the patient developed headache and nausea (table 3) . In patient 2, infusion of VT and isoproterenol facilitation of tachycardia, but in contrast adenosine, vagal maneuvers, and intravenous propranolol had no effect on VT. Intraoperative mapping of VT demonstrated presystolic fractionated activity in the region of the apical septum. Subendocardial resection of this region and aneurysmectomy were performed. During a predischarge electrophysiologic study, VT was no longer inducible and the patient has remained free of VT on no antiarrhythmic agents during 6 months of follow-up.
Another patient (No. 2) with a structurally normal heart but without exercise-induced VT had isoproterenol facilitation of VT but no response to adenosine. Rim". fects of catecholamines that are mediated through stimulation of the adenylate cyclase-cAMP system. 8', 14, 20-22 Based on the data presented in this study and from experimental work in our laboratory and from others, the tachycardia observed in this study is most consistent with cAMP-mediated triggered activity.8' 21, 23-25 For example, in experimentally produced triggered activity in isolated myocytes,8 21' 23 adenosine has been shown to be effective in terminating only triggered activity that is mediated by cAMP. In contrast, adenosine is ineffective in terminating triggered activity caused by either elevated [Ca21]02' or ouabain inhibition of Na,K-ATPase ( figure 5) (unpublished observations) .
Experimental studies suggest that adenosine has little if any effect in infarcted myocardium and reentrant arrhythmias, a finding consistent with our observations in patients with coronary artery disease and reentrant VT. Rosen et al. 24 showed that adenosine had no effect on depressed fast responses in infarcted Purkinje fibers. Furthermore, we have observed that adenosine has no effect on isoproterenol-induced action potential changes in ischemic guinea pig hearts (unpublished observations). It has also been demonstrated that adenosine antagonism of isoproterenol-induced electrophysiologic effects in both isolated ventricular myocytes and multicellular ventricular preparations are markedly blunted when the membrane potential is partially depolarized by increased [K']0.21' 25 These latter observations are consistent with the ineffective response to adenosine in patients with coronary artery disease and isoproterenol facilitated reentrant VT. Finally, we also have provided preliminary evidence to suggest that adenosine has no direct effect on human His-Purkinje system function, since adenosine was ineffective in the one patient studied with VT caused by bundle branch reentry.
The unusual observation that the tachycardia responded to the Valsalva maneuver (group I) provides additional evidence that the VT was mediated by cAMP. Episodes of VT were reproducibly terminated during phase IV of the Valsalva maneuver, a phase that is thought to be mediated by acetylcholine release.26 Acetylcholine exerts its predominant electrophysiologic effect on ventricular myocardium by antagonizing catecholamine-mediated increases in intracellular cAMP27' 28 and has also been shown to terminate catecholamine-induced triggered activity in isolated preparations.3 The termination of tachycardia in response to carotid sinus massage in one patient in this study is also consistent with this mechanism of action. Results of programmed stimulation also lend support to the diagnosis of triggered activity, i.e., initiation of VT after a decrease in sinus, atrial drive, or ventricular drive cycle length. Induction of VT with atrial pacing (patients 2 and 3) has also been suggested to be consistent with triggered activity. 9 However, all these responses observed during programmed stimulation, although suggestive of triggered activity, may also be seen in reentry.12
Verapamil has also been shown to suppress delayed afterdepolarizations and triggered activity29 but is mechanistically nondiscriminant, since it is effective in calcium-induced, ouabain-induced, and catecholamine-cAMP-mediated triggered activity. Furthermore, verapamil may also be effective in treating reentrant arrhythmias in chronically infarcted hearts. 13 Thus termination of a VT with verapamil is not conclusive proof that the rhythm is triggered or cAMP dependent. Therefore, mechanistically, the single most important finding in this study was the consistent termination of the tachycardia by adenosine.
Differentiation between triggered activity and automaticity. Normal automaticity may be distinguished from triggered activity by the inability of programmed stimulation to initiate automatic rhythms. Automatic rhythms also show overdrive suppression, whereas triggered rhythms may be accelerated, terminated, or unaffected by overdrive pacing.30 3' Adenosine is useful in distinguishing between these rhythms because it only transiently depresses normal automaticity but terminates catecholamine-induced, cAMP-mediated triggered activity.8' 21 The tachycardia described in this study was reproducibly initiated by programmed stimulation and was terminated by both programmed stimulation and adenosine, suggesting that an automatic mechanism of VT was unlikely.
Abnormal automaticity, in contrast to normal auto-278 maticity, is characterized by enhanced impulse formation in myocardial cells whose resting membrane potentials are reduced to less than -60 mV.32 Abnormal automaticity is terminated by blockade of the slowinward current; however, adenosine has no effect on this rhythm.24 Thus the ability of adenosine to terminate VT reproducibly in our study should exclude the possibility of abnormal automaticity. Receptor schema. The following receptor schema can explain the pharmacologic and autonomic effects on VT observed in the group I patients with exerciseinduced tachycardia (figure 6). Both acetylcholine and adenosine inhibit cAMP production via a common intracellular pathway, after binding to their respective extracellular inhibitory receptors (R,), i.e., the muscarinic cholinergic and adenosine-A, receptors.22 27 It is thought that coupling of the GTP-dependent regulatory protein (N1) with Ri results in a high-affinity state of the receptor for its agonist. After the agonist binds to the cell receptor, intracellular GTP binds to Ni. This process results in dissociation of Ni from the receptor and inhibition of the catalytic subunit of adenylate cyclase, thereby preventing cAMP formation,3-'36 intracellular calcium overload, afterdepolarizations, and triggered activity. Similarly, fl-adrenergic blockade inhibits the cascade initiated by catecholamines to increase intracellular cAMP (mediated by the GTP-dependent regulatory protein N, (figure 6).36 Verapamil, by blocking the slow-inward calcium current, also prevents intracellular calcium overload and hence can terminate triggered activity without producing direct effects on intracellular cAMP.
Conclusions. The results from this study suggest that in addition to reentry and automaticity, a third clinical mechanism of VT exists, cAMP-mediated triggered activity. We propose that the criteria for diagnosis of this arrhythmia should include appropriate responses 
